Related Experiment Video
Updated: Oct 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Cyclin K as a direct transcriptional target of the p53 tumor suppressor
Toshiki Mori1, Yoshio Anazawa, Kuniko Matsui
1Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
Cyclin K, a newly recognized member of the "transcription" cyclin family, may play a dual role by regulating CDK and transcription. Using cDNA microarray technology, we found that cyclin K mRNA was dramatically increased in U373MG, a glioblastoma cell line deficient in wild-type p53, in the presence of exogenous p53. An electrophoretic mobility-shift assay showed that a potential p53-binding site (p53BS) in intron 1 of the cyclin K gene could indeed bind to p53 protein. Moreover, a heterologous reporter assay revealed that the p53BS possessed p53-dependent transcriptional activity. Colony-formation assays indicated that overexpression of cyclin K suppressed growth of T98G, U373MG and SW480 cells. The results suggested that cyclin K may play a role in regulating the cell cycle or apoptosis after being targeted for transcription by p53.
Insights
Cyclin K, a transcription regulator, is upregulated by p53 in glioblastoma cells. Overexpression of cyclin K inhibits cancer cell growth, suggesting a role in cell cycle or apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- Cyclin K is a novel "transcription" cyclin.
- It may regulate both CDK and transcription.
- Its role in cancer, particularly glioblastoma, is largely unknown.
Purpose of the Study:
- To investigate the regulation of cyclin K by p53.
- To determine the functional impact of cyclin K on cancer cell proliferation.
Main Methods:
- cDNA microarray analysis to assess cyclin K mRNA levels.
- Electrophoretic mobility-shift assay (EMSA) to study p53-DNA binding.
- Heterologous reporter assays to evaluate transcriptional activity.
- Colony-formation assays to assess cell growth suppression.
Main Results:
- Cyclin K mRNA expression was significantly increased in p53-deficient glioblastoma cells upon p53 introduction.
- A specific p53-binding site (p53BS) in intron 1 of the cyclin K gene was identified and shown to bind p53 protein.
- The p53BS demonstrated p53-dependent transcriptional activity.
- Overexpression of cyclin K led to suppressed growth in multiple cancer cell lines (T98G, U373MG, SW480).
Conclusions:
- p53 directly regulates cyclin K transcription via a specific binding site.
- Cyclin K may function as a tumor suppressor by inhibiting cancer cell proliferation.
- Cyclin K is implicated in p53-mediated regulation of cell cycle or apoptosis.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle